Eagle Bay Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Eagle Bay Advisors's AMGN Position: Q1 2026 in Review
Eagle Bay Advisors increased its Amgen (AMGN) stake by 5.3% in Q1 2026, buying an estimated $21K and bringing the position to 1,173 shares worth $413K. The position accounts for 0.36% of the portfolio, ranked #66.
Eagle Bay Advisors first reported a position in AMGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $590K in Q2 2022. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Eagle Bay Advisors held 1,173 shares of Amgen worth $413K as of Q1 2026.
- Eagle Bay Advisors bought 59 Amgen shares in Q1 2026, an estimated $21K.
- Amgen made up 0.36% of Eagle Bay Advisors's portfolio in Q1 2026, its #66 holding.
- Eagle Bay Advisors first reported a position in Amgen in Q2 2021 and has held it in 20 quarters since.
- Eagle Bay Advisors's Amgen position peaked at $590K in Q2 2022.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Eagle Bay Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.